Kimia

Curated by Signal

Provider of a next generation drug discovery engine for mall molecule drugs

Overview

Provider of a next generation drug discovery engine for mall molecule drugs. The company offers a drug discovery engine by combining Chemotype Evolution that enables the rapid synthesis of drugs for novel targets implicated in cancer and immunological disorders.

Key facts

Founded: 2023
Headquarters: Berkeley, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

Open roles

1 role

Senior Software Engineer
Berkeley, CA · On-site · Full-time

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

HourMine
Automated communication tool for doctors
Health TechnologyKirkland, United States
HEALTHeLINK
Solution which allows doctors, with patient consent, to send and receive a patient's clinical data electronically.
Health TechnologyBuffalo, United States
MD Global
App for finding the specialist and home care facility
Health TechnologyAventura, United States

About Kimia

What does Kimia do?

Provider of a next generation drug discovery engine for mall molecule drugs.

Where is Kimia headquartered?

Kimia is headquartered in Berkeley, United States.

When was Kimia founded?

Kimia was founded in 2023.

Which sector is Kimia in?

Kimia operates in Health Technology.

Who are Kimia's competitors?

Companies similar to Kimia include HourMine, HEALTHeLINK, and MD Global.

Is Kimia hiring?

Yes. Kimia has 1 open role listed on Vanberra Signal.